FDA Inspection
Eisai, Inc.Eisai, Inc. – FDA Inspection, Feb 16, 2018
Record Details
This FDA Inspection record concerns Eisai, Inc., with an inspection on February 16, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Jean M. Mulinde (Issuing Officer)
- Lauren C. Iacono-Connors (Issuing Officer)
- Nina Yang (Company Rep)
- Peter R. Lenahan (FDA Associated Person)
View Company Profile
ID · a2dda4fb-11b0-48c4-8bae-404e6e8e2162
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1041308
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.50Ensuring compliance with plan and protocol
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Eisai, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 2, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 9, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 9, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 20, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 17, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Eisai, Inc.
- FDA Inspection 1271039 - 2025-05-02
- FDA Inspection 1198163 - 2023-02-09
- FDA Inspection 965277 - 2015-12-09
- FDA Inspection 922940 - 2015-04-20
- FDA Inspection 813538 - 2013-01-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.